Meningococcal Vaccines: A Progress Report.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 321, doi. 10.2165/00063030-200216050-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2002 AND VI 16 AND IP 5
Results: 9
1
2
Bacterial Genomics: Potential for Antimicrobial Drug Discovery.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 331
- By:
- Publication type:
- Article
3
Iontophoresis-Based Transdermal Delivery Systems.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 339, doi. 10.2165/00063030-200216050-00003
- By:
- Publication type:
- Article
4
Potential of Interferon-α in Solid Tumours: Part 2.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 349, doi. 10.2165/00063030-200216050-00004
- By:
- Publication type:
- Article
5
Profile Summary.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 373, doi. 10.2165/00063030-200216050-00005
- Publication type:
- Article
6
Virulizin.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 374, doi. 10.2165/00063030-200216050-00006
- Publication type:
- Article
7
BMP 2 - Genetics Institute/ Medtronic-Sofamor Danek/Integra: Bone morphogenetic protein 2 - Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, Recombinant human bone morphogenetic protein 2 - Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2 - Genetics Institute/Medtronic-Sofamor Danek/Integra.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 376, doi. 10.2165/00063030-200216050-00007
- Publication type:
- Article
8
Amediplase: CGP 42935, K2tu-PA, MEN 9036.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 378
- Publication type:
- Article
9
Omalizumab: Anti-IgE monoclonal antibody E25, E25, Humanised anti-IgE MAb, IGE 025, Monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
- Published in:
- BioDrugs, 2002, v. 16, n. 5, p. 380, doi. 10.2165/00063030-200216050-00009
- Publication type:
- Article